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A B S T R A C T
Berries are rich sources of (poly)phenols which have been associated with the prevention of cardiovascular
diseases in animal models and in human clinical trials. Recently, a berry enriched diet was reported to decrease
blood pressure and attenuate kidney disease progression on Dahl salt-sensitive rats. However, the relationship
between kidney function, metabolism and (poly)phenols was not evaluated. We hypothesize that berries pro-
mote metabolic alterations concomitantly with an attenuation of the progression of renal disease. For that,
kidney and urinary metabolomic changes induced by the berry enriched diet in hypertensive rats (Dahl salt-
sensitive) were analyzed using liquid chromatography (UPLC-MS/MS) and 1H NMR techniques. Moreover,
physiological and metabolic parameters, and kidney histopathological data were also collected. The severity of
the kidney lesions promoted in Dahl rats by a high salt diet was significantly reduced by berries, namely a
decrease in sclerotic glomeruli. In addition, was observed a high urinary excretion of metabolites that are in-
dicators of alterations in glycolysis/gluconeogenesis, citrate cycle, and pyruvate metabolism in the salt induced-
hypertensive rats, a metabolic profile counteracted by berries consumption. We also provide novel insights that
relates (poly)phenols consumption with alterations in cysteine redox pools. Cysteine contribute to the redox
signaling that is normally disrupted during kidney disease onset and progression. Our findings provide a vision
about the metabolic responses of hypertensive rats to a (poly)phenol enriched diet, which may contribute to the
understanding of the beneficial effects of (poly)phenols in salt-induced hypertension.
1. Introduction
(Poly)phenols include a family of secondary metabolites that are
present in plant-derived foods and their intake has been associated to a
lower risk of cardiovascular diseases (CVDs), namely by reducing blood
pressure [1,2]. Flavonoids are one of the main classes of (poly)phenols
which have beneficial effects on renal physiology, but their effects on
the progression of kidney disease are still poorly studied. Their main
mechanisms of action are thought to be their impact on the
inflammatory process, besides its in vitro antiapoptotic and antifibrotic
properties (reviewed in Ref. [3]).
Recently we demonstrated that a (poly)phenol-enriched diet atte-
nuated the progression of hypertension and renal hypertrophy in Dahl
salt-sensitive (Dahl/SS) rats [4]. The berry mixture not only increased
survival and maintained the body weight of the rats, but also amelio-
rated the systolic blood pressure (SPB), and improved cardiac and
kidney function [4]. The association between hypertension and renal
disease is a well-accepted condition with no effective treatment
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available. In that view, our previous work opens an avenue for the
development of new preventive and/or therapeutic strategies. More-
over, a greater understanding of the cellular and metabolic alterations
underlying the effect of (poly)phenols on kidney disease progression is
of utmost relevance for this worldwide health crisis lacking therapeutic
options.
An important aspect needed to be clarified is the identity of the
metabolites resulting from (poly)phenols administration and con-
sumption, that are responsible for their beneficial properties [3]. In that
sense, in our preceding work, we demonstrated the metabolic fate of
(poly)phenols in Dahl/SS rats after the ingestion of a berry-enriched
diet, which was responsible for the beneficial effects observed. More-
over, we showed that berries had the ability to modulate the compo-
sition of the rat's gut microbiota [5].
Several studies based on metabolomics techniques have reported
metabolite changes in serum, urine and kidney tissues in chronic kidney
disease [6–8]. Metabolomics methodologies are effective for mon-
itoring changes in small molecules, induced by internal and external
factors and could, therefore, constitute an important tool for under-
standing the complex renal disease events. They identify biochemical
signatures related to the disease pathogenesis that could be used for the
diagnosis, monitoring of the disease progression and evaluation of the
response to therapeutic interventions [9]. In recent years, metabo-
lomics has been used to assess nutritional status and facilitate the dis-
covery of new biomarkers associated with specific nutrients (food me-
tabolome) or forms of metabolic dysfunction [10–12]. However, the
relationship between (poly)phenols, kidney function, and metabolism is
still not clear.
To understand the metabolic alterations associated with renal dis-
ease and the effects of diet on their progression, the metabolomic
changes induced by a (poly)phenol enriched diet in urine and kidney of
Dahl/SS rats were analyzed using UPLC-MS/MS and 1H NMR techni-
ques. These metabolites profile was related to phenotypic traits in-
cluding physiological and metabolic parameters, as well as with kidney
histopathological data. We also aimed to provide novel insights in how
(poly)phenols can modulate kidney disease onset and progression by
impacting the thiol pools. Despite historically defined as an imbalance
of pro-oxidants and antioxidants, the current evidence supports that
glutathione (GSH) redox pool might not be equilibrated with the other
redox pools. In that view, oxidative stress may be better defined as a
disruption of redox signaling through discrete redox pathways [13].
Comparatively to the GSH-rich liver, the kidney is an organ rich in
cysteine, the glutathione precursor. In fact, the main pathway of glu-
tathione catabolism towards cysteine replenishment (cysteinylglycine
as intermediary step) is a hallmark to kidney tubular cell [14], and
kidneys represent one of the tissues with the highest expression of
cysteine disulfide transporters [15]. This non-essential amino acid is the
most predominant thiol in plasma, mostly in its oxidized form – low
molecular weight cysteine disulfides and protein bound cysteine (pro-
tein cysteinylation, CysSSP). Together with the de novo cysteine
synthesis by the transsulfuration pathway, circulating cystine is the
major source of intracellular cysteine to support several cellular pro-
cesses. Overall, we evaluated changes in kidney thiols pools and relate
them with the metabolic alterations induced by salt and the effect of
berries consumption.
2. Material and methods
2.1. Diet preparation and animal experiments
The mixture of blueberries (Vaccinum spp. variety Georgia Gem),
blackberries (Rubus L. subgenus Rubus Watson variety Karaka Black)
and raspberries (Rubus idaeus L. variety Himbo Top) harvested at the
Fataca experimental field in Odemira, Portugal; strawberry tree fruits
(Arbutus unedo L.) harvested in the Alentejo region, Portugal, and
Portuguese crowberries (Corema album L.) harvested in the Comporta
region, Portugal, was prepared as described previously [4,5,16]. The
berry mixture (poly)phenol content and the profiles before and after
inclusion in rats’ diets (LS and HS) was analyzed as described in the
preceding papers [4,5] (supplementary tables S1 and S2) and it was in
compliance with the chemical characterization already done for the
fruits individually and in the mixture [16,17].
The animal trial was carried out at the platform AnimEx, which
belongs to the Châtenay-Malabry Faculty of Pharmacy from the
University Paris-Sud, following the experimental design and nutritional
treatments as previously published in the former work [4,5]. Briefly,
male Dahl-salt sensitive rats (SS/JrHsdMcwiCrl strain [18] obtained
from Charles River L'Abresle, France) were maintained in a room at
22 ± 1 °C, with an artificial 12/12 h light/dark cycle. After acclima-
tion for 1 week with access to the AIN-76a powder chow (INRA UPAE,
Jouy-en Josas, France) (supplementary table S1) and water, rats were
randomly divided into 4 groups. Rat powder chow (50 g) was prepared
fresh every day by mixing the regular AIN-76a with or without lyo-
philized berry mixture: 1) low salt diet enriched with 0.26% NaCl (LS);
2) low salt diet enriched with 0.26% NaCl and supplemented with 2 g of
lyophilized berry mixture (LSB); 3) hypersaline diet enriched with 8%
NaCl (HS); and 4) hypersaline diet enriched with 8% NaCl, and sup-
plemented with 2 g of lyophilized berry mixture (HSB) (Fig. 1). Food
and water were available ad libitum in both the home and metabolic
cages. At week 4 and 9 of the trial, all rats were housed in metabolic
cages and body weight, food, water intake, as well as urinary volume
were measured daily for three days (Fig. 1). For metabolomic analysis,
Fig. 1. Flowchart of the trial. A berry mixture was supplemented or not in the food to LS diet rats (LS and LSB) and HS diet rats (HS and HSB) for 10 weeks.
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rats were fasted overnight.
All animal care and experimental procedures were performed ac-
cording to the European Community guiding principles in the care and
use of animals (Directive 2010/63/EU of the European Parliament) and
authorizations to perform animal experiments according to this direc-
tive were obtained from the French Ministry of Agriculture, Fisheries
and Food (No. D-92-283, 13 December 2012). The Ethical Committee of
the University of Paris-Sud, France approved all animal research pro-
tocols (N°APAFIS#2152–2015092912128144 v3). All studies involving
rats are reported in accordance with the ARRIVE guidelines for re-
porting experiments involving animals.
2.2. Urine and kidney collection
For collection of urine, rats were allocated at the 9th week into
metabolic cages for 4 days, with 24 h adaptation period before urine
collection (Fig. 1). After, samples were centrifuged at 3000 g for
5 min at 7 °C. A total of 500 μL of urine were acidified with 100 μL of
50% Milli-Q water/formic acid (v/v), followed by storage at −20 °C
until further analysis.
At the end of the experiment (after 9 weeks), animals were sacri-
ficed by decapitation without any anaesthetic drug (Fig. 1). Kidneys
were excised from the rats, sections of kidney were fixed in formalin for
histopathological examinations, and the remaining tissue was frozen in
liquid N2 immediately after collection, freeze-dried and stored at
−80 °C until further analysis.
2.3. UPLC-ESI-MS/MS analysis of phenolic metabolites in kidney
In order to clean-up the biological matrix and pre-concentrate the
phenolic compounds, kidney tissues were sequentially pre-treated by a
combination of liquid–solid extraction (LSE) and microelution solid-
phase extraction (μSPE) [19–22]. The methodologies were followed
according to previous publications [5,23].
Briefly, 50 μL of ascorbic acid (1%), and 150 μL of phosphoric acid
(4%) were added to 60 mg of freeze-dried kidney. Each sample was
treated four times with 400 μL of extraction solution (water/methanol/
phosphoric acid 4%; 94/4.5/1.5, v/v/v). Then, the samples were so-
nicated (S-150D Digital SonifierR Cell Disruptor, Branson, Ultrasonidos
S.A.E., Barcelona, Spain) for 30 s maintaining the sample in an ice
water bath, and then centrifuged for 15 min at 8784 g at 20 °C. The
supernatants were collected, and 350 μL of the extract of kidney was
pre-treated by μSPE using the sample methodology previously de-
scribed [20].
The analysis of phenolic metabolites in kidney was performed using
a UPLC coupled to tandem MS (MS/MS). The chromatographic system
is an AcQuity Ultra-PerformanceTM liquid chromatography and tandem
MS from Waters (Milford MA, USA), as previously reported [5,22].
For the (poly)phenol metabolites identified in the kidney by UPLC-
MS/MS, the non-parametric Kruskal–Wallis and Dunn's tests were ap-
plied to analyze significant differences (p < 0.05) between groups.
The Kruskal–Wallis test was applied to determine any significant dif-
ference between the treatments and, if any were detected, Dunn's test
was used to compare all the different pairs of the treatments. Data are
expressed as mean concentrations (nmol/g fresh kidney) with standard
error of the mean (SEM). The Prism 7 for Mac OS X, version 7.0a was
used.
2.4. Histopathological assessment of the kidney
Formalin-fixed paraffin-embedded kidney sections were cut into 7-
μm sections and mounted on slides. The kidney sections were subjected
to the standard Masson's trichrome and McMannus periodic acid –
Schiff staining protocols [24] from which glomerular, interstitial and
vessels injury index were calculated to quantitate renal injury. In each
group, 8 fields of each kidney were observed with 200× magnification.
Glomerular, interstitial and vessel lesions severity was graded ac-
cording to the percentage of total glomeruli, interstitial and vessels
affected as follows: stage 0, no lesions; stage 1, 1–25% injury; stage 2,
26–50% injury; and stage 3, 51–100% injury. In the glomeruli, lesion
severity was also assessed taking into account their segmental or global
aspect (all samples were blindly evaluated by a nephropathologist).
2.5. Cysteine availability and protein cysteinylation in kidney
To address total cysteine availability and cysteinylated protein
pools, kidneys were excised from the rats, frozen in liquid N2 im-
mediately after collection freeze-dried and stored at −80 °C until
further use. Lyophilized tissue was sonicated in PBS1x and centrifuged
at 13 000 g, for 5 min at 4 °C. Then the supernatant was aliquoted to
proceed with cysteine fraction quantification by HPLC as previously
described [25]. Multiple comparisons between results from groups were
done using two-way ANOVA with Bonferroni post-test (GraphPad Prism
version 7.0a).
2.6. Urine 1H NMR metabolomic analysis
Prior to the metabolomic analysis, the urine samples were thawed
on ice and mixed using a vortex mixer. The samples were centrifuged
(12 000 g, 15 min at 4 °C) and 400 μL of the supernatant was mixed
with 300 μL of chloroform and 200 μL methanol. Samples were agitated
for 15s and then incubated on ice for another 15 min. Then, samples
were centrifuged (12 000 g, 15 min at 4 °C) and 400 μL of supernatant
were dried overnight using a speed vacuum concentrator at 30 °C. Dried
samples were resuspended in 200 μL phosphate buffer (100 mM sodium
phosphate buffer, pH 7.4, containing 0.1–0.5 mM 3-trimethylsilylpro-
pionic acid (TSP) and optionally 0.2% NaN3) and 400 μL D2O. The
samples were mixed again, and finally, an aliquot of 560 μL was
transferred into a 5 mm NMR tube [26].
Urine samples were analyzed with proton (1H) NMR spectroscopy
on an 800 MHz Bruker AvanceII+(Ettlingen, Germany) spectrometer
equipped with a room temperature triple resonance HCN Z-gradient
probe, at 298 K. 1H 1D-NOESY spectra (spectral width: 20 ppm; mixing
time: 0.01 s; relaxation delay: 4 s; acquisition time: 4 s) were collected
for each urinary sample using the “noesygppr1d” pulse sequence fol-
lowing the parameters for profiling recommended from Chenomx NMR
Suite software (Chenomx Inc., Edmonton, Canada). All spectra were
processed with a line broadening (lb) of 0.5 Hz and a final number of
128 K points.
For the most concentrated sample of each group, additional spectra
were collected to assist with assignment, namely J-Resolved and 1H–1H
COSY. Spectra were processed and analyzed using TopSpin3.2 software
(Bruker, Ettlingen, Germany).
Metabolite identification and quantification was carried out using
Chenomx NMR Suite 8.12 software (Chenomx Inc., Edmonton, Canada),
using the internal reference library (Version 10). Chemometric analysis
of the raw data was also performed on binned spectra using the
“nmrprocflow” platform. Bins were obtained using manually curated,
intelligent binning after referencing, baseline correction, water signal
removal and peak alignment.
2.7. NMR data analysis
A total of 491 NMR bin areas were analyzed using the metabolomic
data processing server MetaboAnalyst 4.0 [27].
2.7.1. Multivariate statistical analysis
Multivariate statistical analysis was carried out on the extracted bin
intensities. Data were pre-processed for normalization and scaling in
order to remove possible bias from sample variability and preparation.
Data were filtered according to the interquantile range, normalized for
LS group and submitted to pareto scaling (mean-centered and divided
A. Gomes, et al. Free Radical Biology and Medicine 154 (2020) 119–131
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by the square root of the standard deviation of each variable).
Normalized data were subsequentially analyzed by Principal
Component Analysis (PCA) to detect intrinsic clusters and outliers
within the data. To maximize separation between samples, Partial Least
Squares - Discriminant Analysis (PLS-DA) with default parameters of
MetaboAnalyst was applied. Models were tested using R2 and Q2
parameters, where R2 provides a measure of how much variation is
represented by the model and Q2 for the goodness and prediction. After
building the PLS-DA model, variable importance in projection (VIP)
score of each variable was used to rank the identified distinctive fea-
tures based on their significance in discriminating between the 4 groups
in analysis. Variables with VIP score > 1 were selected as significant
bins. The value of VIP score which is greater than 1 is the typical rule
for selecting relevant variables [28,29].
2.7.2. Univariate statistical analysis
To determine if changes in NMR bin intensities were statistically
significant, one-way Analysis of Variance (ANOVA) followed by post-
hoc Fisher's least significant difference method (Fisher's LSD) were
applied using the online Metabolomic Data Analysis with
MetaboAnalyst [27]. Altered bins were considered significant when p
values were less than 0.05.
2.7.3. Pathway analysis
The assignment of the spectral bins was done by Chenomx NMR
Suite 8.12 software (Chenomx Inc., Edmonton, Canada), using the in-
ternal reference. Then, pathway analysis was conducted with
MetaboAnalyst [27] uploading the assigned metabolites statistical sig-
nificantly different from ANOVA analysis within all groups using the
default parameters with Rattus norvegicus pathway library from KEGG.
3. Results
3.1. Effect of salt and a (poly)phenol enriched diet on Dahl/SS rat's
metabolic parameters
We recently demonstrated the beneficial effects of a berry-enriched
diet in a chronic model of hypertension-induced heart failure, the Dahl/
SS rats, and assessed how the metabolic fate of (poly)phenols is affected
under pathological conditions and the associated microbiota alterations
[4,5]. The berry mixture provided to the hypertensive rats promoted an
increased survival, maintained their body weight, ameliorated systolic
blood pressure (SPB) (supplementary figure S1) and cardiac function
and decreased cardiac and renal hypertrophy [4]. Moreover, alterations
in metabolic fate of (poly)phenols were concomitant to gut microbiota
modulation in hypertensive rats suggesting a bidirectional relationship,
between metabolites and microbiota environments [5].
Irrespective of the addition of berries in the diet, from week 4, rats
on HS diets started to show higher water intake and urinary volume
(Table 1); this phenomenon was maintained until the end of the trial.
Although not significant, there was a trend of a decreased food intake at
9 weeks by the rats in the HS diet when compared to the LS diet and
berry-enriched diet tend to prevent this decline. This could be under-
lying in the differences observed in body weight, once HS rats present
lower body weight. Interestingly, the (poly)phenol enriched diet pre-
vented the reduction of the body weight promoted by the HS diets at 9
weeks (Table 1).
3.2. Kidney histomorphological modifications on hypertensive Dahl/SS rats
are reduced by a berry-enriched diet
No histological abnormalities were found in the kidneys of the LS
and LSB rats at 9 weeks (Fig. 2A-2D) rats. In contrast, kidney tissues
from the HS rats, at the end of the trial, showed glomerulosclerosis
(indicated with an asterisk (*) in the representative section of Fig. 2A),
and inflammatory cell infiltration (indicated with an arrow in the re-
presentative section of Fig. 2A). A recovery in the kidney morphology
was observed suggesting some renoprotection by the ingestion of the
diet supplemented with the berries (Fig. 2A-2D).
3.3. (Poly)phenol metabolites are more retained in kidney of Dahl/SS rats
Metabolites from berry (poly)phenols were identified and quantified
by UPLC-MS/MS in rats' kidneys. A total of 41 (poly)phenol metabolites
and their respective concentrations were determined in rat's kidneys at
the end of the trial, independently of the diet (Table 2).
Hippuric acid was (Table 2) one of the most abundant (poly)phenol
metabolites in kidney samples in the 4 groups, and its concentration
was significantly higher in rats that consumed a high salt diet supple-
mented with the berry mixture (HSB, p < 0.01). Protocatechuic acid
sulfate was accumulated in higher amounts in HS and HSB rat kidneys.
In fact, this was the metabolite which clearance was most affect if we
compare LSB and HSB rat's, the retention of protocatechuic acid in the
kidneys is significantly higher in HSB in relation to LSB group.
From the 41 (poly)phenol metabolites, 7 of them were only present
in the kidneys of rats that consumed berries, irrespective of the salt
content in the diet (Table 2). Moreover, there were 14 metabolites
exclusively identified in HSB rats’ kidneys (Table 2) from which 36%
belonged to the flavanols derivatives class, 21% were cinnamic acid
derivatives, 14% were pyrogallol derivatives, and catechol, benzoic
acid, valeric acid and valerolactone derivatives represented 7.1% each.
In fact, 95% of these metabolites detected are in higher concentrations
in HSB rat kidneys.
3.4. Berries restore the salt-induced metabolic alterations in urine of Dahl/
SS rats
3.4.1. 1H NMR spectra analysis
The metabolic profile of urine samples from the 9th week of the trial
was deduced from the spectral features of 1H NMR. Principal
Component Analysis (PCA) was performed on the profiled compound
bin intensities for all groups (Fig. 3A). The bins were later identified
Table 1
Influence of high salt diet and berry-enriched diet on metabolic parameters at 4 and 9 weeks of diet.
4th Week 9th Week
Food intake (g) Body weight (g) Water intake (mL) Urinary volume (mL) Food intake (g) Body weight (g) Water intake (mL) Urinary volume (mL)
LS 25.8 ± 4.4 289.0 ± 5.2 32.6 ± 2.8 10.3 ± 2.0 17.0 ± 0.7 375 ± 5.6 18.2 ± 1.6 11.3 ± 1.4
LSB 23.0 ± 3.4 288.0 ± 5.1 28.3 ± 4.8 10.0 ± 1.1 19.7 ± 1.8 377 ± 5.2 17.8 ± 3.3 9.8 ± 2.0
HS 24.5 ± 2.3 286.0 ± 4.8 80.9 ± 7.5*** 58.9 ± 5.1*** 13.1 ± 2.4 303 ± 16.7** 62.4 ± 10.2** 42.9 ± 5.2***
HSB 23.6 ± 1.5 289.0 ± 3.4 82.9 ± 5.6$$$ 60.4 ± 3.2$$$ 19.8 ± 2.6 349 ± 5.2#$$ 55.6 ± 5.2$$$ 47.7 ± 3.8$$$
Metabolic parameters are represented as mean ± SEM of values at 4 weeks of diet for 6 rats in the LS and LSB groups, 12 rats in HS and 16 rats in HSB group. At 9
weeks, data are represented as mean ± SEM of values from 6 rats in the LS and LSB groups, from 8 rats in HS group and 12 rats in HSB group. **p < 0.01,
***p < 0.001 versus LS; $$ p < 0.01, $$$ p < 0.001 vs LS Berries; #p < 0.05 vs HS.
LS – Low Salt diet; LSB – Low Salt diet supplemented with a berry mixture; HS – High Salt diet; HSB – High Salt diet supplemented with a berry mixture.
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using database assisted spectral deconvolution. The clear separation
between the LS and HS groups suggests different metabolic states,
pointing to a marked alteration of urinary metabolites that could be
related with the observed kidney injuries. When berries are added to
the low salt diet (LSB) the change in the metabolic profile from the
regular low salt samples (LS) is marginal since they overlap regions in
PCA analysis. Interestingly when berries are added to the diet of the
animals already with high salt (HSB group), the metabolic signature
changes in a much more dramatic manner. The introduction of berries
in the high salt diet seems to disrupt the clear separation between LS
and HS creating an intermediate group.
Subsequent PLS-DA analysis corroborates the group separation.
There is a clear separation between LS and HS samples independently of
the presence of the berries (Fig. 3B) that is supported by the statistical
robustness of the analysis. Our model scored high R2 = 0.94 and
Q2 = 0.49, confirming good predictive power (Fig. 3C).
Key differentiating features (i.e. spectral bins) identified by PLS-DA
analysis were sorted by increasing VIP value score (Fig. 4A, the top 30
bins with VIP > 1 are presented). Considering VIP value > 1 as cut-
off, 57 features (spectral bins) were found to be significant dis-
criminators between the 4 groups. A heatmap of relative intensity
changes potentially differentiating NMR signals (from PLS-DA/VIP
analysis) was then composed to visualize possible clustering (Fig. 4B).
Indeed, a clear pattern emerges that shows the clustering of the samples
according to the salt and or berries presence in the diets.
After this initial evaluation, we performed ANOVA followed by
Fisher's LSD test (p < 0.05) and we were able to identify the statisti-
cally significant bins between all the groups (Supplementary Figure S2).
Fisher's LSD test classified 78 spectral bins as statistically significant
(p < 0.05; Supplementary Table S3). Correlation analysis, including
the p values from the Fisher's test and the false discovery rates (FDR) is
consistent with the results obtained from multivariate analysis (PLS-
DA/VIP analysis), meaning that both methods identified almost the
same significantly changing bins between the 4 groups.
3.4.2. Urinary metabolites identification
For a biochemical interpretation of the observed spectral differ-
ences, we attempt to assign the bins to their respective metabolites. For
that, each bin was represented by its peak chemical shift value that was
then related to a metabolite using the internal reference library
(Version 10) from the Chenomx NMR Suite 8.12 software (Chenomx
company, Edmonton, Canada).
From the statistically significant spectra bins obtained by the
Fisher's test, 37 metabolites were unequivocal assigned (supplementary
table S3). Almost 36% of the statistically significant spectral bins were
assigned to different metabolites that include amino acids, organic
acids, sugars, among others. However, a significant number of NMR
signal regions could not be unequivocally assigned due to the signal
overlap and/or low sensitivity. For the top 10 significantly altered
metabolites (p < 0.05) the relative concentrations in urine of rats from
all the 4 groups are presented (Fig. 5).
3.4.3. Pathway analysis
Pathway analysis was first performed for all metabolites sig-
nificantly altered within all groups and with VIP values higher than 1.
Significantly altered pathways (p < 0.05) that had also high impact
values include butanoate metabolism, citrate cycle, alanine, aspartate
and glutamate metabolism, synthesis and degradation of ketone bodies,
D-glutamine and D-glutamate metabolism, glycolysis or gluconeogenesis
metabolism and nicotinate and nicotinamide metabolism (Table 3).
Pathway significance is determined from pathway enrichment analysis
and based on each compound in the data set. The impact value, on the
other hand, is determined by pathway topology analysis. Impact is
determined based upon the importance of a metabolite within a
pathway; a metabolite that is found at a junction point within a
pathway may have a greater impact on the pathway function if the level
Fig. 2. Histomorphological analysis of Masson stained rats' kidney. (A) Light microscopy images of kidney stained with Masson's trichrome (200×, original mag-
nification). Representative images are presented for each group, * indicates glomerulosclerosis and the arrow indicates inflammatory cell infiltration; (B) Glomerular
injury score; (C) Interstitial injury and (D) Vessels injury score. Glomerular, interstitial and vessels lesions severity was graded according to the percentage of total
glomeruli, interstitial and vessels injury involved as follows: stage 0, no lesions; stage 1, 1–25% injury; stage 2, 26–50% injury; and stage 3, 51–100% injury (all
samples were blindly evaluated by a nephrologist).heat-map representing the severity of the legions: interstitial infiltrate, glomerular and vessels injuries; (C) total
injuries score. N = 5 rats/group. ***p < 0.001 vs LS, $p < 0.05 and $$$p < 0.001 vs LSB, #p < 0.05 vs HS. LS, Low-salt diet; LSB, LS diet supplemented with a
berry mixture; HS, high salt diet; HSB, HS diet supplemented with the berry mixture.
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is altered.
In Table 3 the results from the pathway analysis are presented.
Taurine and hipotaurine metabolism result as a pathway with a high
impact value, although its p value was not significant. The impact value
for this pathway was high because taurine is located at a junction
within the pathway. On the other hand, aminoacyl-tRNA biosynthesis
pathway presented a significant p value but not a high impact value.
The pathway with both significant p value and high impact was D-
glutamine and D-glutamate metabolism (Table 3).
When looking in detail for the pathways affected between LS and HS
(Fig. 6A), results revealed that feeding a high salt diet for 9 weeks in-
duced significant metabolic alterations (p < 0.05) and also with
impact in metabolites from pathways such as glycolysis or gluconeo-
genesis (namely ethanol, lactate and acetate), citrate cycle (citrate and
succinate), and pyruvate metabolism (acetate and lactate), resulting in
the increase of their relative concentrations in rats urine. Regarding
taurine and hipotaurine metabolism, and glyoxylate and dicarboxylate
metabolism despite being not significant (p > 0.05) had a high impact
value, since taurine is a central metabolite in this pathway. The pre-
sence of salt in the diet decreases the relative concentration of taurine
found in urine (Fig. 6E. When we compare LS and LSB (Fig. 6B) in order
to understand the effect of the berries in the metabolism, we identify 5
metabolic pathways with significance of which 2 were more affected by
berry mixture supplementation, namely butanoate metabolism and
Table 2
(Poly)phenols metabolites in kidneys of the rats fed with a LS, LSB, HS and HSB at 9 weeks of trial.
(Poly)phenols metabolites in kidney (nmol/g fresh tissue)
LS LSB HS HSB
Benzoic acid derivatives
Vanillic acid sulfate 0.4 ± 0.1 0.3 ± 0.2 0.3 ± 0.1 1.8 ± 1.1
Hydroxybenzoic acid1 0.9 ± 0.1 1.1 ± 0.2 1.2 ± 0.2 1.6 ± 0.2
Hydroxybenzoic acid sulfate1 0.6 ± 0.1 1.3 ± 0.3 1.0 ± 0.1 4.8 ± 0.6###
4-O-methylgallic acid n.d 0.3 ± 0.2 n.d 0.7 ± 0.1
4-O-methylgallic acid sulfate n.d 0.7 ± 0.4 n.d 0.7 ± 0.1
Protocatechuic acid sulfate1 3.0 ± 1.3 0.2 ± 0.2 19.2 ± 4.0 17.0 ± 6.6
Syringic acid n.d n.d n.d 1.2 ± 0.1
Syringic acid sulfate n.d 0.4 ± 0.2 n.d 1.3 ± 0.1
Cinnamic acid derivatives
Coumaric acid1 n.d 0.3 ± 0.2 n.d 0.2 ± 0.1
Coumaric acid sulfate1 0.4 ± 0.1 1.6 ± 0.4 1.6 ± 0.3 7.3 ± 1.3##
Coumaric acid glucuronide1 n.d n.d n.d 0.1 ± 0.01
Caffeic acid sulfate1 n.d 0.4 ± 0.2 1.0 ± 0.2 2.6 ± 0.3 $$##
Caffeic acid glucuronide1 n.d 0.2 ± 0.1 n.d 0.1 ± 0.1
Dihydrocaffeic acid n.d n.d n.d 0.4 ± 0.3
Dihydrocaffeic acid sulfate 0.7 ± 0.3 0.5 ± 0.3 1.6 ± 0.4 3.3 ± 0.4 $$#
Ferulic acid n.d n.d 0.5 ± 0.1 0.8 ± 0.1
Ferulic acid sulfate n.d 0.2 ± 0.03 n.d 0.9 ± 0.1
Dihydroferulic acid sulfate n.d n.d n.d 0.2 ± 0.1
Dihydroferulic acid glucuronide 0.1 ± 0.03 0.07 ± 0.4 0.4 ± 0.1 0.5 ± 0.3
Propionic acid derivatives
3-(Phenyl)propionic acid 0.4 ± 0.1 0.4 ± 0.02 1.1 ± 0.1 1.3 ± 0.1 $$
3-(hydroxyphenyl) propionic acid1 1.0 ± 0.7 5.2 ± 2.9 0.9 ± 0.2 1.6 ± 0.2
(Hydroxyphenyl)propionic acid sulfate1 0.6 ± 0.1 6.7 ± 2.1 5.8 ± 0.9 33.0 ± 5.0##
Hippuric acid derivatives
Hippuric acid 3.3 ± 0.7 11.7 ± 1.3 9.9 ± 1.6 46.3 ± 10.0##
Phenylacetic acid derivatives
2-(Phenyl)acetic acid 0.8 ± 0.1 1.6 ± 0.2 *** 2.9 ± 0.3 4.6 ± 1.4
2-(Hydroxyphenyl)acetic acid 0.9 ± 0.1 1.2 ± 0.3 ** 2.9 ± 0.6 2.9 ± 0.2
2-(Trihydroxyphenyl)acetic acid1 n.d 0.2 ± 0.1 n.d 0.4 ± 0.2
Catechol derivatives
Catechol n.d n.d n.d 0.4 ± 0.1
Catechol sulfate 1.1 ± 0.1 1.7 ± 0.020 0.8 ± 0.05 1.4 ± 0.1##
4-methyl catechol sulfate1 0.5 ± 0.05 0.4 ± 0.016 0.7 ± 0.08 0.8 ± 0.07 $
Hydroxytyrosol 0.9 ± 0.4 n.d 2.4 ± 0.6 2.9 ± 1.4
Pyrogallol derivatives
Pyrogallol sulfate1 n.d n.d n.d 0.118 ± 0.0274
2-methyl pyrogallol sulfate n.d n.d n.d 0.176 ± 0.0344
Flavanols derivatives
Methylepicatechin sulfate1 n.d n.d n.d 0.232 ± 0.158
Epicatechin glucuronide1 n.d n.d n.d 0.2 ± 0.1
Methylepicatechin glucuronide1 n.d n.d n.d 0.4 ± 0.2
Catechin glucuronide1 n.d n.d n.d 0.4 ± 0.1
Methylcatechin sulfate1 n.d n.d n.d 0.9 ± 0.2
Methylcatechin glucuronide1 n.d 1.1 ± 0.1 0.4 ± 0.2 2 ± 0.3###
Valeric acid derivatives
5-(Hydroxyphenyl)valeric acid1 n.d n.d n.d 0.2 ± 0.08
Valerolactone derivatives
5-(Dihydroxyphenyl)-δ-valerolactone1 n.d n.d n.d 0.1 ± 0.09
5-(Dihydroxyphenyl)-δ-valerolactone sulfate1 n.d 0.08 ± 0.05 n.d 0.3 ± 0.1
(Poly)phenols metabolites determined in kidney are represented as mean ± SEM of values at 9 weeks of diet for 6 rats in the LS and LSB groups, from 8 rats in HS
group and 12 rats in HSB group. **p < 0.01, ***p < 0.001 versus LS; $$ p < 0.01, $$$ p < 0.001 vs LS Berries; #p < 0.05, ##p < 0.01, ###p < 0.001 vs
HS. 1It is possible to have more than one isomer for this compound, however since it was not confirmed by standards we cannot attribute a specific identity due to the
same MS/MS fragmentation profile; n.d.: not detected; LS – Low Salt diet; LSB – Low Salt diet supplemented with a berry mixture; HS – High Salt diet; HSB – High Salt
diet supplemented with a berry mixture.
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Fig. 3. Multivariate analysis for all sample groups. (A) Two-dimensional PCA score plot of all four groups at week 9 of diet intervention. (B) Two-dimensional PLS-DA
score plot of all four groups at week 9 of diet intervention. (C) PLS-DA classification using different numbers of components. The red asterisk indicates the best
classifier. The inset table summarizes Q2, R2 and accuracy of the best model. Comps means number of components. LS, Low-salt diet; LSB, LS diet supplemented with
a berry mixture; HS, high salt diet; HSB, HS diet supplemented with the berry mixture.
Fig. 4. Significant features (spectral bins) discriminating between all sample groups at week 9 of diet intervention. (A) Important features identified by PLS-DA and
VIP scores. Only spectral bins with a significant VIP value > 1 are included as recommended by the literature. The coloured boxes on the right indicate relative bin
integral for all 4 samples. Variable Importance in Projection is a weighted sum of squares of the PLS loadings taking into account the amount of explained Y-variation
in each dimension. (B) Heatmap of unsupervised hierarchical clustering. The heatmap was constructed from the most significantly differing bins (features), as
identified by PLS-DA and VIP scores. Each coloured cell on the map corresponds to a relative concentration value. Red and blue colour denote increased and
decreased bin integrals, respectively. LS, Low-salt diet; LSB, LS diet supplemented with a berry mixture; HS, high salt diet; HSB, HS diet supplemented with the berry
mixture.
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citrate cycle, since relatives concentrations of metabolites such as suc-
cinate and citrate are higher in urine of LSB rats than in LS rats. Me-
tabolites such as lactate, acetate and acetoacetate that belong to path-
ways like pyruvate metabolism, glycolysis and gluconeogenesis, and
synthesis and degradation of ketone body's metabolism were in lower
amounts in urine of rats that consumed the LS diet supplemented with
berries (LSB).
Regarding the effects of the berries in the metabolism of rats fed
with a high salt diet, 3 metabolic pathways were affected such as citrate
cycle, alanine, aspartate and glutamate metabolism and also taurine
and hypotaurine metabolism (Fig. 6C). Concerning specific metabolite
changes between these two groups, HS diet increased creatinine con-
centration in urine, while supplementation with the berries decreased
it. By contrast, hippurate concentration increased in urine due to the
berries and in less amount in urine of HS rats.
In order to understand which metabolic pathways were affected by
a high salt content in diets supplemented with berries, we compared
LSB and HSB rats’ urine (Fig. 6D). The metabolic pathways significantly
different and with more impact were related to pyruvate metabolism,
starch and sucrose metabolism, glycolysis or gluconeogenesis and ga-
lactose metabolism. Starch and sucrose metabolism, and galactose
metabolism were affected due to the presence of high amounts of salt in
the diet, by decreasing the relative concentration of compounds (su-
crose and glucose) implicated in these pathways.
3.4.4. Berry-enriched diet modulate cysteine catabolism in hypertensive rats
Some of the compounds identified by 1H NMR belong to metabolic
pathways related to carbon and energy metabolism, and they can result
from the catabolism of cysteine. Moreover, we have previously de-
scribed changes in protein cysteinylation in kidney of an animal model
of hypertension and insulin resistance without histologic alterations in
kidney [30]. Changes in cysteine availability and variations in cysteine
dynamics were also address in the present work. A simplified metabolic
flow chart illustrating the pathways of cysteine metabolism evaluated
in this work are represented in Fig. 7A. Cysteine dioxygenase (CDO)
catalyzes the first step in the major cysteine catabolic pathway, and
shunts cysteine toward the production of pyruvate and taurine. Other
two products of cysteine metabolism are glutathione (GSH) and hy-
drogen suphide (H2S).
Our results showed that, while salt-induced hypertension did not
increase cysteine total availability (Fig. 7B) (reduced + free oxi-
dized + protein bound), there was a decrease in cysteine total avail-
ability in HSB group (Fig. 7B). In fact, in this group the total availability
of the precursor Cysteinylglycine (CysGly, glutathione catabolism pro-
duct and source of cysteine) was decreased (Fig. 7C) as well as total
availability of glutathione (Fig. 7D). Regarding to the cysteine fraction
bound to protein (CysSSP) it is increased in HS group and berries
supplementation to this group decrease it (Fig. 7E).
4. Discussion
Berries or pure (poly)phenols-enriched diets have (direct or sys-
temic) cardioprotective effects in various cardiovascular preclinical
models as well as in humans [31–33]. We recently showed the bene-
ficial effects of berry-(poly)phenol enriched diet ingestion in the
chronic model of hypertension-induced heart failure, the Dahl-salt
sensitive rats [4]. The berries mixture provided to the hypertensive rats
prolonged their lifespan, maintained their body weight, ameliorated
systolic blood pressure (SPB) and cardiac function, and decreased car-
diac and renal hypertrophy [4]. Moreover, for the same animals, we
demonstrated that the high salt diet, responsible for the development of
hypertension in the rats influenced the excretion of (poly)phenol me-
tabolites in urine and feces of the Dahl-salt sensitive rats as well as
modulated the microbiota composition [5]. In the present work, we
Fig. 5. Boxplot of relative concentrations for the top 10 significantly altered metabolites (p < 0.05) in urine of rats from all the 4 groups. The Y-axis scale is relative.
Data were normalized to a pooled sample from the LS group. Due to this normalization process we obtained negative scale in the Y-axis on some of the bins (analysis
performed by the online program MetaboAnalyst). The bar plots show the normalized values (mean ± standard deviation). The box ranges from 25% and the 75%
percentiles; the 5% and 95% percentiles are indicated as error bars; single data points are indicated by black dots. Medians are indicated by horizontal lines within
each box. LS, Low-salt diet; LSB, LS diet supplemented with a berry mixture; HS, high salt diet; HSB, HS diet supplemented with the berry mixture.
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identified unexpected differences in the retention of (poly)phenol me-
tabolites in kidney and in the metabolic profiles of urine. Moreover, we
evaluated histological alterations of kidney tissues from Dahl-salt sen-
sitive rats either in a LS and HS diets supplemented with berries, to
better understand the metabolic changes that occur in the end of the
trial on the different diets. Since, many phenotypic traits that are
common to hypertension in man (including sodium sensitivity of hy-
pertension, reduced renal function, elevated urinary excretion of pro-
tein and albumin, and a low plasma renin), are described to be present
in the Dahl-salt sensitive rats [34], we herein addressed the systemic
effects of a berry-enriched diet on kidney that could indirectly impact
heart function.
Dahl-salt sensitive rats developed renal injury after 9 weeks on a
high salt diet (HS), in contrast to the rats on low salt diets supplemented
or not with the berry mixture. Remarkably, on rats fed a high salt diet
supplemented with berries (HSB), there was a lower extent in the se-
verity of the kidney injuries than the lesions observed in the HS kidneys
rats (Fig. 2). The renal injury consisted of mild vascular injury with
some features of glomerular ischemia, glomerulosclerosis and tubu-
lointerstitial changes with accumulation of inflammatory cells in the
interstitial space [35]. Both glomerular and tubulointerstitial injuries
were detected in rats with a high salt diet (HS) and were ameliorated in
some extent in rats that consumed berries (HSB). Moreover, we
previously showed that these rats fed with an HSB diet presented an
improvement in the salt-induced cardiac dysfunction. In addition,
beneficial effects of berries on kidney were observed, with a decrease in
kidney weight and improved function in comparison with the rats in an
HS diet as shown by differences in terms of creatinuria and renal
clearance [4]. Thus, cardioprotective effects of the berry mixture may
be due to their systemic effects on other organs targeted by hyperten-
sion, such as the kidney that could impact indirectly on the heart.
Beside the decreased severity of the lesions promoted by berries in
kidneys of rats in a HS diet (Fig. 2)we observed a differential retention
of some (poly)phenol metabolites in HSB rat kidneys, probably as
consequence of functional differences between the kidneys of HS and
HSB. In fact, as previously described we observed low creatinuria va-
lues in urine of HS rats, that was almost recovered to control levels (LS)
when rats were fed with the diet supplemented with berries [4].
In the present study, the metabolic profiles in kidney tissues re-
vealed that 14 (poly)phenol metabolites were accumulated exclusively
in HSB rats’ kidneys (Table 2). However, whether the degree of renal
injuries induced by salt, namely the malfunctioning of the renal
transporters promoted (poly)phenols retention in Dahl-salt sensitive
rats remains unclear.
Studies suggest that kidney is a critical organ for the regulation of
salt homeostasis and also to be responsible for the regulation of drug
transporters, CYP-metabolizing enzymes and nuclear receptors
Moreover, a decreased expression of the drug transporter Mdr1b was
observed in rat kidney fed a high salt diet [36]. This fact was associated
with the decreased level of aldosterone secretion or angiotensin II
promoted by a high-salt diet [37]. One of the kidney transporters in-
volved in the efflux of hydrophilic compounds, such as (poly)phenols, is
the P-glycoprotein (MDR1/ABCB1) [38]. Since studies demonstrate that
its expression in kidneys was decreased due to the high salt diet, the
retention of (poly)phenol metabolites observed in our study, may be
due to a lower Mdr1b expression. Moreover, the epithelial Na+ channel
(ENaC) in the kidney plays a key role in the regulation of blood pressure
by contributing to the Na+ reabsorption in renal tubules. In fact, in a
study performed by Aoi W and co-authors they demonstrated that
dietary quercetin supplementation reduces the blood pressure elevated
by HS diet in Dahl-salt sensitive rats, and that this is associated with
αENaC expression in the kidney [39]. These observations suggest that
one of the mechanisms of the flavonoid's antihypertensive effect would
be mediated through the downregulation of αENaC expression in the
kidney [39], however, more studies should be done to attribute this
beneficial effect to the (poly)phenols present in our berry mixture and
in particular to the biological (poly)phenol metabolites accumulated in
this organ.
The metabolic alterations detected in the urine analysis by 1H NMR
revealed that feeding rats with a high salt diet (HS) for 9 weeks induced
significant increase of glycolysis, citrate cycle, pyruvate metabolism,
alanine, aspartate and glutamate metabolism, aminoacyl-tRNA bio-
synthesis, and glycine, serine and threonine metabolism. Wang Le. and
co-workers also demonstrated that some of these metabolic pathways
were altered in kidneys of the Dahl-salt sensitive rats [40], namely five
citrate cycle metabolites and pyruvate, which connects citrate cycle and
glycolysis, were increased in the plasma of the animals. Their results
demonstrate that abnormalities of citrate cycle in Dahl/SS rats may play
a role in predisposing these rats to developing salt-sensitive hyperten-
sion. Similarly, our results showed an increase in the glycolysis and
gluconeogenesis metabolites, citrate metabolism, namely citrate and
succinate, and also in pyruvate metabolism in the urine of HS rats
compared to rats in a LS diet. Moreover, a recent study also demon-
strated that high salt diets had an impact in metabolic pathways in the
kidney that were associated with high blood pressure in Dahl/SS rats
[41]. Regarding the effects of the berries in the metabolism of rats fed
with a high salt diet, 3 metabolic pathways were affected, such as ci-
trate cycle, alanine, aspartate and glutamate metabolism and also
taurine and hypotaurine metabolism. The diet supplementation with
Table 3
Pathway analysis performed for all metabolites significantly altered within all
groups and with VIP values higher than 1 using the online software
MetaboAnalyst.
Pathways Totala Hitsb p value FDRc Impactd
Butanoate metabolism 20 5 8.560E-05 0.007 0.101
Citrate cycle (TCA cycle) 20 4 0.001 0.048 0.173
Alanine, aspartate and glutamate
metabolism
24 4 0.002 0.066 0.323
Synthesis and degradation of
ketone bodies
5 2 0.005 0.094 0.600
D-Glutamine and D-glutamate
metabolism
5 2 0.006 0.094 1.000
Aminoacyl-tRNA biosynthesis 67 5 0.023 0.289 0
Glycolysis or Gluconeogenesis 26 3 0.025 0.289 0.029
Nicotinate and nicotinamide
metabolism
13 2 0.040 0.402 0.363
Glyoxylate and dicarboxylate
metabolism
16 2 0.058 0.525 0.148
Propanoate metabolism 20 2 0.087 0.686 0
Arginine and proline metabolism 44 3 0.094 0.686 0.169
Pyruvate metabolism 22 2 0.102 0.686 0.055
Starch and sucrose metabolism 23 2 0.110 0.686 0.0378
Biotin metabolism 5 1 0.118 0.686 0
Glutathione metabolism 26 2 0.136 0.686 0.055
Galactose metabolism 26 2 0.136 0.686 0.077
Taurine and hypotaurine
metabolism
8 1 0.184 0.850 0.429
Glycine, serine and threonine
metabolism
32 2 0.189 0.850 0
Nitrogen metabolism 9 1 0.204 0.870 0
Histidine metabolism 15 1 0.317 1.000 0
Selenoamino acid metabolism 15 1 0.317 1.000 0
beta-Alanine metabolism 19 1 0.383 1.000 0
Porphyrin and chlorophyll
metabolism
27 1 0.498 1.000 0
Valine, leucine and isoleucine
degradation
38 1 0.622 1.000 0
Pyrimidine metabolism 41 1 0.651 1.000 0.021
Tyrosine metabolism 42 1 0.660 1.000 0
Primary bile acid biosynthesis 46 1 0.693 1.000 0.030
a Total – Total of compounds from the pathway.
b Hits – Number of metabolites identified in that pathway.
c FDR- False Discovery Rate.
d Impact - importance of a metabolite within a pathway; a metabolite that is
found at a junction point within a pathway may have a greater impact on the
pathway function if the level is altered.
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berries decreased some metabolites such as creatinine, succinic acid,
citrate and alanine, which were increased due to HS diet.
He et al., demonstrate that succinic acid increases blood pressure in
animals, and that the hypertensive effect of succinic acid is mediated by
GPR91 through the activation of the renin–angiotensin system [42].
Moreover, in a clinical study, the measurement of estimated glomerular
filtration rate (eGFR), which is considered the best available indicator
of the overall function of the kidneys, was evaluated in normotensive
and hypertensive patients and related with alterations in plasma free
amino acids and uric acid. Alanine presented a significant positive as-
sociation with reduced eGFR exclusively for the hypertension group
[43]. Citrate is also a metabolic substrate in the kidneys and was also
altered in urine of HS fed. Moreover urinary citrate levels were also
found increased in patients with resistant hypertension [44] Thus, our
study, which measured berries effect on the metabolism of hypertensive
rats revealed that a (poly)phenol enriched diet had an impact in mul-
tiple metabolic pathways which dysfunction is associated with hy-
pertension.
Some of the compounds identified in this study belong to metabolic
pathways related to carbon and energy metabolism and they can also
result from the catabolism of cysteine. We observe that a high salt diet
did not increase cysteine total availability (Fig. 7B) (reduced + free
oxidized + protein bound) but increased CysSSP (Fig. 7E), however
berries promoted a decrease in cysteine total availability, CysGly glu-
tathione and CysSSP. This might indicate that there is a metabolic
switch for cysteine catabolism (Fig. 7A). It is known that the catabolism
of cysteine might include the activity of cysteine dioxygenase (CDO)
with production of pyruvate and taurine (Fig. 7A) [45].
In fact, pyruvate is the key initiator of the citrate cycle, one of the
most significant altered pathways by berries (Fig. 6B and C). Moreover,
from the top significant altered spectral bins in urine of rats, two were
assigned as citrate cycle metabolites (succinic acid and oxoglutaric acid,
Fig. 5), and their relative concentrations are lower in urine of hy-
pertensive rats fed with a diet supplemented with berries. Another as-
signed metabolite, also with lower relative concentrations in the HSB
rats urine was glutamic acid. It can be converted to oxoglutaric acid,
again one of the metabolites involved in the citrate cycle. The fact that
glutamic acid levels are lower could also interfere with the glutamyl
cycle, which is also involved in the synthesis of cysteine.
The other byproduct from CDO activity is taurine. However, CDO
modulation by berries might not be the case as taurine levels were
lower in urine of this animals (Fig. 6E). Although phenolic compounds
are described as natural products modulators of the nuclear factor er-
ythroid 2-related factor 2 (Nrf2), a redox sensitive transcription factor
that controls CDO1 [46,47], overall our data suggest that cysteine
catabolism was not through CDO activity.
Moreover, glutamylcysteine ligase (GCL), previously known as
gamma-glutamylcysteine synthetase (GCS) competes with CDO for cy-
steine, it controls the availability of cysteine, GSH and H2S production
[45]. However, we have a decrease in total GSH and CysGly when rats
diet was supplemented with berries suggesting that cysteine is not being
used for GSH metabolism.
Besides taurine and pyruvate, the degradation of cysteine generates
H2S (Fig. 7A) and, the conversion by H2S producing enzymes (cy-
stathionine β-synthase (CBS) and cystathionine γ-lyase (CSE)) are well
documented as downregulated in kidney disease [48]. Given the cyto-
protective, antioxidant and anti-inflammatory effects of H2S an increase
in the synthesis of H2S can be one of the benefits promoted by berries
Figure 6. Metabolome view from pathway analysis performed using MetaboAnalyst (Select pathways with high impact and/or high p value). The graphics contain all
the matched pathways arranged by p values (from pathway enrichment analysis) on Y-axis, and pathway impact values (from pathway topology analysis) on X-axis.
The node colour is based on its p value and the node radius is determined based on their pathway impact values. The pathways that were most significantly changed
are characterized by both a high-log(p) value and high impact value (top right region of the graphic). Pathway analysis results from the effects of (A) the high salt
diet: LS vs HS, (B) the berries mixture: LS vs LSB, (C) the berries mixture in a high salt diet: HS vs HSB, and (D) the presence of salt in the berries mixture: LSB vs HSB.
(E) Taurine 1H NMR quantification (nmol) in urine at 9 weeks.
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compounds. Additionally, berries supplementation in the hypertensive
rats (HSB) showed a reversion in the increased protein cysteinylation
(CysSSP) levels observed in the HS fed rats (Fig. 7E) that also might
involve CBS activity [49]. Interestingly, this observation is opposite to
the one observed in a model of hypertension without renal impairment
where low protein cysteinylation in kidney was observed [30], that
might indicate an inverse relationship with protein cysteinylation at the
kidney function.
Another cysteine source is homocysteine that is a precursor of cy-
steine upon irreversible vitamin B6 -dependent transsulfuration
pathway, through CBS activity that might be decreased in kidney dis-
ease, as mentioned above [48]. Kidney is a relevant organ for homo-
cysteine excretion and Cheng et al. (2018) have demonstrated that
homocysteine was the only metabolite showing a significant association
with differences in blood pressure, between low and high sodium in-
takes by participants of the DASH-Sodium trial, which suggests that
homocysteine might have a particularly important relationship with
changes in sodium intake that warrants further investigation [50]. We
might hypothesize that berries might be facilitating the metabolism of
homocysteine into cysteine, and cysteine further catabolism through an
effect on CBS or increasing its cofactors. Accordingly, Cheng et al.
(2018) showed that together with homocysteine, also urinary cystine
was increased and associated with both SBP and DPB. This increased in
urinary cystine might also indicate a lower capability tubular re-
absorption by an impairment of one (more) of its different transporters
at tubular apical membrane [15], and/or a higher increase in cystine in
plasma which is an independent factor for cardiovascular morbidity
[51].
The presented results suggest that berries promoted an increase in
the metabolic use of cysteine by the organism, that is reflected by its
decreased levels, as a strategy to better cope with kidney dysfunction
observed in the hypertensive rats.
5. Conclusions
Our study demonstrates the effects of a (poly)phenol enriched diet
in multiple metabolic pathways in urine and kidney associated with
hypertension, namely by impacting cysteine dynamics, already de-
scribed as antihypertensive. These findings support the efficacy of
phytochemical-enriched diets against hypertension-associated kidney
pathology. This association may have particular importance to our
aging population, which has reduced intake of both fruit and vege-
tables.
In our work we used a dietary approach that was able to promote an
increase in the metabolic use of cysteine. It have been already described
that early cysteine supplementation can prevent the kidney damage
associated to high salt intake [52]. By giving a (poly)phenol enriched
diet we were able to demonstrate the same potential. This data opens
the avenue for further exploitation of the use of a dietary intervention
as a tool for the prevention of kidney disease.
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